全文获取类型
收费全文 | 1134篇 |
免费 | 87篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 44篇 |
妇产科学 | 26篇 |
基础医学 | 197篇 |
口腔科学 | 5篇 |
临床医学 | 95篇 |
内科学 | 178篇 |
皮肤病学 | 15篇 |
神经病学 | 51篇 |
特种医学 | 8篇 |
外科学 | 150篇 |
综合类 | 30篇 |
一般理论 | 1篇 |
预防医学 | 103篇 |
眼科学 | 13篇 |
药学 | 110篇 |
肿瘤学 | 178篇 |
出版年
2018年 | 8篇 |
2015年 | 11篇 |
2014年 | 22篇 |
2013年 | 20篇 |
2012年 | 23篇 |
2011年 | 29篇 |
2010年 | 16篇 |
2009年 | 18篇 |
2008年 | 22篇 |
2007年 | 29篇 |
2006年 | 25篇 |
2005年 | 34篇 |
2004年 | 33篇 |
2003年 | 27篇 |
2002年 | 24篇 |
2001年 | 25篇 |
2000年 | 39篇 |
1999年 | 31篇 |
1998年 | 11篇 |
1995年 | 11篇 |
1994年 | 12篇 |
1993年 | 17篇 |
1992年 | 22篇 |
1991年 | 31篇 |
1990年 | 27篇 |
1989年 | 36篇 |
1988年 | 45篇 |
1987年 | 44篇 |
1986年 | 30篇 |
1985年 | 32篇 |
1984年 | 29篇 |
1983年 | 30篇 |
1982年 | 18篇 |
1981年 | 12篇 |
1980年 | 9篇 |
1979年 | 25篇 |
1978年 | 29篇 |
1977年 | 22篇 |
1976年 | 8篇 |
1975年 | 7篇 |
1974年 | 25篇 |
1973年 | 32篇 |
1972年 | 26篇 |
1971年 | 14篇 |
1970年 | 23篇 |
1969年 | 15篇 |
1968年 | 14篇 |
1967年 | 16篇 |
1966年 | 19篇 |
1965年 | 7篇 |
排序方式: 共有1221条查询结果,搜索用时 31 毫秒
1.
2.
3.
John Lister 《Sociology of health & illness》2006,28(7):992-995
4.
T. Hickish P. Serafinowski D. Cunningham A. Oza E. Dorland I. Judson B. C. Millar T. A. Lister A. Roldan 《British journal of cancer》1993,67(1):139-143
2''-Chlorodeoxyadenosine (2CDA) is a purine analogue selectively active against both resting and dividing lymphoid cells. Twenty-one patients with a variety of previously treated lymphoid malignancies received a total of 41 courses of 2CDA (0.1-0.15 mg/kg/day over 7 days continuous intravenous infusion) on compassionate grounds. The profile of the patient population was as follows: low grade non-Hodgkin''s lymphoma (NHL) = 8, intermediate grade NHL = 2, transformed (intermediate grade NHL) = 6, Hodgkin''s disease = 1, lymphoplasmacytoid NHL = 3 and lymphoblastic NHL = 1. The overall response rate was 53%, with three patients attaining complete remission (CR) and eight partial remission (PR). Three of 16 patients with primary resistant or resistant recurrent disease entered either CR (1) or PR (2). Ten patients had no response or progressive disease. The latter group was comprised of patients who had extensively pre-treated lymphoplasmacytoid tumours and/or poor performance status (WHO grades 2-4). The median duration of response is 6 months (range 1 to 12 months). Treatment was well tolerated and the chief toxicities were leucopenia and thrombocytopenia which were most pronounced when there was bone marrow involvement. As a result of dose limiting myelotoxicity, a dose escalation to 0.15 mg/kg/day was possible on just three occasions. These data confirm other reports of the activity of 2CDA in low grade NHL and indicate it may have activity in Hodgkin''s disease. There was no demonstrable activity in poor performance status patients or those with extensively pre-treated lymphoplasmacytoid tumours. 相似文献
5.
T S Ganesan H S Dhaliwal M S Dorreen A G Stansfeld J A Habeshaw T A Lister 《British journal of cancer》1987,55(4):437-442
Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed. Clinical features at presentation included rash, fever, lymphadenopathy and hepatosplenomegaly in 75% of patients. Polyclonal hypergammaglobulinaemia was seen in 19/20 patients; 5 had normal immunoglobulin levels. Combination chemotherapy with MVPP was the optimal treatment with 6/7 patients achieving complete remission. Duration of remission ranged from 9 months to 4 years and was significantly longer in patients achieving complete as opposed to partial remission. In 6 patients phenotype studies were performed on single cell suspensions and immunoperoxidase studies on frozen sections of 7 lymph nodes. There was a reversal of the normal T suppressor/helper cell ratio with a predominance of T suppressor cells. Loss of normal B follicles was observed histologically in all except one lymph node. Germline configuration of the beta B-chain of the T cell receptor was observed in lymph nodes of 4 patients with AILD, and a rearranged T cell receptor was observed in 1 patient in whom a second lymph node biopsy had shown alteration of the histological picture to that of T-zone lymphoma. Frozen sera of 15 patients were screened for antibodies to HTLV I and III and were found to be negative. 相似文献
6.
7.
The mean concentrations of immunoreactive substance P in cerebrospinal fluid (CSF) of 10 fetuses (gestational age 11-20 weeks) were 22.7 +/- 8.3 pmol/ml, compared with 250.0 +/- 28.2 fmol/ml in premature babies (gestational age 25-31.5 weeks, n = 8), 141.0 +/- 14.2 fmol/ml in full term newborn babies (n = 5), 50.0 +/- 2.3 fmol/ml in children (age 1-6 years, n = 6), and 9.5 +/- 1.5 fmol/ml in 5 adults. The differences between successive age groups were all statistically significant. The high concentration of substance P in human CSF in the early stages of development and its continuous decline towards maturity encourages the idea that substance P plays a role in neuro-development. 相似文献
8.
Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples 总被引:6,自引:0,他引:6
Pearce DJ Taussig D Simpson C Allen K Rohatiner AZ Lister TA Bonnet D 《Stem cells (Dayton, Ohio)》2005,23(6):752-760
Aldehyde dehydrogenase (ALDH) is a cytosolic enzyme that is responsible for the oxidation of intracellular aldehydes. Elevated levels of ALDH have been demonstrated in murine and human progenitor cells compared with other hematopoietic cells, and this is thought to be important in chemoresistance. A method for the assessment of ALDH activity in viable cells recently has been developed and made commercially available in a kit format. In this study, we confirmed the use of the ALDH substrate kit to identify cord blood stem/progenitor cells. Via multicolor flow cytometry of cord blood ALDH+ cells, we have expanded on their phenotypic analysis. We then assessed the incidence, morphology, phenotype, and nonobese diabetic/ severe combined immunodeficiency engraftment ability of ALDH+ cells from acute myeloid leukemia (AML) samples. AML samples had no ALDH+ cells at all, an extremely rare nonmalignant stem/progenitor cell population, or a less rare, leukemic stem cell population. Hence, in addition to identifying nonmalignant stem cells within some AML samples, a high ALDH activity also identifies some patients' CD34+/ CD38- leukemic stem cells. The incidence of normal or leukemic stem cells with an extremely high ALDH activity may have important implications for resistance to chemotherapy. Identification and isolation of leukemic cells on the basis of ALDH activity provides a tool for their isolation and further analysis. 相似文献
9.
The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma 总被引:27,自引:0,他引:27
P A Hall M A Richards W M Gregory A J d'Ardenne T A Lister A G Stansfeld 《The Journal of pathology》1988,154(3):223-235
The monoclonal antibody Ki67 recognizes an antigen expressed in all phases of the cell cycle except Go. It has been used in 141 biopsies from 138 patients with non-Hodgkin's lymphoma to identify proliferating cells in histological sections. A Ki67 index (the number of Ki67 positive tumour cells divided by the sum of Ki67 positive and negative tumour cells) has been derived by counting 1000 cells in each case. A correction for the presence of non-tumour cells has been incorporated by counting non-tumour cells in serial sections stained with a panel of other antibodies. A very strong correlation between a low Ki67 index (less than 20 per cent) and low grade histology and a high Ki67 index (greater than 20 per cent) and high grade histology was found (Chi2 = 98.0). Ninety-one patients could be analysed for survival and those with low grade lymphoma (n = 38) who had a relatively high Ki67 index (greater than 5 per cent) had a worse survival than those with an index of less than 5 per cent (p less than 0.05). In contrast, there was a trend for those patients with high grade disease with a very high Ki67 index (greater than 80 per cent) to have a better survival than those with a lower index (less than 80 per cent). The patients with high grade disease who achieved complete remission or good partial remission and had a Ki67 index of less than 80 per cent were more likely to relapse than those with an index of greater than 80 per cent (p less than 0.04). These findings could not be explained by the effect of other prognostic factors such as age, stage, or serum albumin. While the use of Ki67 immunostaining has potential drawbacks, it appears to be a simple and reproducible method of determining a tumour proliferative index which provides relevant clinical data. 相似文献
10.